Zum Hauptinhalt springen Zur Suche springen Zur Hauptnavigation springen
Dekorationsartikel gehören nicht zum Leistungsumfang.
Buprenorphine
Pharmacology, Clinical Uses & Potential Side Effects
Sprache: Englisch

198,95 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Lieferzeit 2-3 Wochen

Produkt Anzahl: Gib den gewünschten Wert ein oder benutze die Schaltflächen um die Anzahl zu erhöhen oder zu reduzieren.
Kategorien:
Beschreibung
Buprenorphine was introduced in the United States as an injectable analgesic in 1981 and treatment option for opioid dependence in 2002; a transdermal formulation was approved for pain management in 2010. Following the introduction of this variety of dosage forms, buprenorphine use and misuse have increased significantly. This book begins by reviewing the pharmacology of buprenorphine and co-ingredient naloxone; its use in addiction medicine and pain management; and clinical challenges, with special emphasis on drug-drug interactions (pharmacokinetic and pharmacodynamic), safety concerns, and buprenorphine misuse. The book continues to discuss the role of buprenorphine as an analgesic; the application of buprenorphone in acute and chronic pancreatitis; and the substitution maintenance treatment of opioid dependence with buprenorphine and naloxone.
Buprenorphine was introduced in the United States as an injectable analgesic in 1981 and treatment option for opioid dependence in 2002; a transdermal formulation was approved for pain management in 2010. Following the introduction of this variety of dosage forms, buprenorphine use and misuse have increased significantly. This book begins by reviewing the pharmacology of buprenorphine and co-ingredient naloxone; its use in addiction medicine and pain management; and clinical challenges, with special emphasis on drug-drug interactions (pharmacokinetic and pharmacodynamic), safety concerns, and buprenorphine misuse. The book continues to discuss the role of buprenorphine as an analgesic; the application of buprenorphone in acute and chronic pancreatitis; and the substitution maintenance treatment of opioid dependence with buprenorphine and naloxone.
Details
Erscheinungsjahr: 2014
Medium: Buch
Inhalt: Gebunden
ISBN-13: 9781633211360
ISBN-10: 1633211363
Sprache: Englisch
Einband: Gebunden
Hersteller: Nova Science Publishers Inc
Verantwortliche Person für die EU: preigu, Ansas Meyer, Lengericher Landstr. 19, D-49078 Osnabrück, mail@preigu.de
Maße: 237 x 157 x 19 mm
Erscheinungsdatum: 01.08.2014
Gewicht: 0,476 kg
Artikel-ID: 133448523
Details
Erscheinungsjahr: 2014
Medium: Buch
Inhalt: Gebunden
ISBN-13: 9781633211360
ISBN-10: 1633211363
Sprache: Englisch
Einband: Gebunden
Hersteller: Nova Science Publishers Inc
Verantwortliche Person für die EU: preigu, Ansas Meyer, Lengericher Landstr. 19, D-49078 Osnabrück, mail@preigu.de
Maße: 237 x 157 x 19 mm
Erscheinungsdatum: 01.08.2014
Gewicht: 0,476 kg
Artikel-ID: 133448523
Sicherheitshinweis

Ähnliche Produkte

Ähnliche Produkte

Taschenbuch
-17 %